Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses. Huang F, Goncalves C, Bartish M, Remy-Sarrazin J, et al. J Clin Invest 2024;134:e181575.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huang F, Goncalves C, Bartish M, Remy-Sarrazin J, et al. Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses. J Clin Invest 2024;134:e181575.
PMID: 38690739